-
Product Insights
Cachexia – Drugs In Development, 2023
Global Markets Direct’s, ‘Cachexia - Drugs In Development, 2023’, provides an overview of the Cachexia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cachexia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Muscle Wasting Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Muscle Wasting Disorders - Drugs In Development, 2023’, provides an overview of the Muscle Wasting Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Muscle Wasting Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Sarcopenia – Drugs In Development, 2023
Global Markets Direct’s, ‘Sarcopenia - Drugs In Development, 2023’, provides an overview of the Sarcopenia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sarcopenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Sector Analysis
Western Europe Consumer Health Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Western Europe Consumer Health Market Overview The Western Europe Consumer Health market size was $46.4 billion in 2022. The market is likely to grow at a CAGR of more than 2% during 2022-2027. Based on the relative performance of countries on multiple metrics, the UK, Switzerland, the Netherlands, and Sweden were shortlisted as high-potential countries, primarily due to their large consumer health industry sizes. Western Europe Consumer Health Market Outlook 2022-2027 ($ Billion) Buy the Full Report for More Insights...
-
Product Insights
Aventi Energias – Santo Augusto Wind Power Plant 120 MW – Rio Grande do Sul
Equip yourself with the essential tools needed to make informed and profitable decisions with our Aventi Energias - Santo Augusto Wind Power Plant 120 MW - Rio Grande do Sul report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Sector Analysis
Middle East and Africa (MEA) Consumer Health Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Middle East and Africa (MEA) Consumer Health Market Report Overview The Middle East and Africa (MEA) consumer health market size was valued at $12.4 billion in 2022. The market is expected to achieve a CAGR of more than 1% during 2022-2027. With rising obesity rates and lifestyle diseases, people in the Middle East and Africa region are becoming more aware of the importance of maintaining a healthy lifestyle, including regular exercise and proper nutrition. The MEA consumer health market research...
-
Sector Analysis
Eastern Europe Consumer Health Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Eastern Europe Consumer Health Market Report Overview The Eastern Europe consumer health market size was valued at $10.8 billion in 2022. The market is expected to achieve a CAGR of more than 1% during 2022-2027. Based on the relative performance of countries on multiple metrics, Romania, Hungary, Slovakia, and Poland were shortlisted as high-potential countries, primarily owing to their large consumer health industry sizes. chemists/pharmacies was the leading distribution channel in the Eastern Europe consumer health industry in 2022. Eastern...
-
Company Profile
NewSanofi India Ltd – Company Profile
Sanofi India Ltd (Sanofi India), a subsidiary of Sanofi, is a healthcare company. It focuses on a range of therapeutic areas including diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines. The company's product portfolio includes insulin, tablets, vaccines and injection. Sanofi India offers products under the brands Lantus, Allegra, Combiflam, Amaryl, Clexane, Targocid, Frisium, Cardace, Adenocor, Cetapin, Cordarone, Daonil, Myoril, Synvisc, Valparin, Lemtrada, among others. The company has two manufacturing sites in Ankleshwar and Goa. Sanofi India is...
Add to Basket -
Sector Analysis
Over-the-Counter Healthcare Market Opportunities, Trends, Growth Analysis and Forecast to 2027
OTC Healthcare Market Overview The OTC healthcare market size was valued at $169.2 billion in 2022 and the market is expected to record a CAGR of more than 2% during 2022-2027. Japan, Malaysia, Canada, the US, the UK, Switzerland, Hungary, Romania, UAE, and Nigeria are considered high-potential countries, due to their large OTC healthcare sector sizes, projected high-value growth rates, and projected rising per capita value levels. OTC Healthcare Market Outlook 2022-2027 (USD Billion) For more insights on the OTC...
-
Sector Analysis
Asia-Pacific (APAC) Consumer Health Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Asia-Pacific Consumer Health Market Report Overview The Asia-Pacific (APAC) consumer health market size was valued at $124.4 billion in 2022. The region was the second-largest market in the global consumer health industry in 2022 and is expected to achieve a CAGR of more than 4% during 2022-2027. In the APAC region, people are increasingly seeking consumer health products, especially in the sports & active nutrition sector that offer a unique experience. The APAC consumer health market research report brings together...